Autopsy report · NCT00764699

Effect of Increlex® on Children With Crohn Disease

“PI left institution”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 7 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 7 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Nationwide Children's Hospital

Sponsor type

University, hospital or other

Conditions

Crohn Disease

Interventions

rhIGF (Increlex)

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
  “PI has left Institution” (96% match in meaning)
• Cilostazol After Lower Extremity Arterial Revascularization Trial
  “Original PI left institution” (94% match in meaning)
• rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures
  “PI left the institution” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.